TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 502 participants.
Also called NCT01134393
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 502 participants
- Sponsor
- Registry
-
NCT01134393 -
2009-017336-40
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- Not reported
- Results first posted
- Countries
- Germany, Italy, Mexico, Netherlands, Poland
- Registry status
- Completed
Technical summary
Registry record NCT01134393. Non-randomized; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2011-05 (actual). Results posted on 2012-07-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch
- Condition
- Hypertension
- Intervention (Drug)
- telmisartan/amlodipine
- Lead sponsor
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct01134393- Content hash
3081bf4c810996e9c7de2bdc215ba825af729202b4aa6573ca3a985fe700902e